Medix Biochemica, a global leader in critical IVD raw materials, has acquired all of the shares of Diaclone SAS ("Diaclone"). Through acquisition, Medix Biochemica broadens its portfolio of critical raw materials for the in-vitro diagnostics ("IVD") industry and expands its global network.

On May 16, Mindray Medical announced that it intends to acquire 100% of the equity of HytestInvest Oy in Finland and its subsidiaries.

The 1st Key Raw Material & Parts Forum of China, sponsored by China Association of In Vitro Diagnostics (CAIVD), was held in Chongqing Yuelai International Conference Center on March 28, 2021.

The 1st Key Raw Material & Parts Forum of China, organized by China Association of In Vitro Diagnostics (CAIVD), is scheduled to be held in Chongqing Yuelai International Convention Center on March 28, 2021.